Chemoinformaics analysis of Orcinol gentiobioside
| Molecular Weight | 448.421 | nRot | 6 |
| Heavy Atom Molecular Weight | 420.197 | nRig | 13 |
| Exact Molecular Weight | 448.158 | nRing | 3 |
| Solubility: LogS | -4.342 | nHRing | 2 |
| Solubility: LogP | 4.425 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 1 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 6 |
| nHA | 12 | APOL | 60.0242 |
| nHD | 8 | BPOL | 35.0338 |
| QED | 0.62 |
| Synth | 5.54 |
| Natural Product Likeliness | 3.028 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.007 |
| HIA | 0.014 |
| CACO-2 | -4.537 |
| MDCK | 0.0000172 |
| BBB | 0.63 |
| PPB | 0.922937 |
| VDSS | 1.319 |
| FU | 0.0879606 |
| CYP1A2-inh | 0.139 |
| CYP1A2-sub | 0.73 |
| CYP2c19-inh | 0.129 |
| CYP2c19-sub | 0.901 |
| CYP2c9-inh | 0.278 |
| CYP2c9-sub | 0.845 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.755 |
| CYP3a4-inh | 0.1 |
| CYP3a4-sub | 0.348 |
| CL | 14.642 |
| T12 | 0.074 |
| hERG | 0.011 |
| Ames | 0.02 |
| ROA | 0.751 |
| SkinSen | 0.041 |
| Carcinogencity | 0.036 |
| EI | 0.065 |
| Respiratory | 0.869 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.593157 |